CompletedEUCTR 2012-004457-88
A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized-withdrawal Study to Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years with Moderate to Severe Binge Eati...
This historical record does not confirm current site availability.
Historical research recordMultiple countriesEating disorders
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Germany · Spain and 1 more location
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 412
- Sponsor
- Shire Development LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Germany, Spain, Sweden
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2012-004457-88
- Official title
Show the full official title
A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized-withdrawal Study to Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years with Moderate to Severe Binge Eati...
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedGermany · Spain · Sweden
Questions about this study
Who is behind this study?
The study sponsor is Shire Development LLC.
